INTRODUCTION
As the world is facing increasing cases of multidrug-resistant bacteria, there is an urgent need to search for novel antibacterial compounds.
Besides synthetic inhibitors, potential sources of antibacterial compounds include those derived from natural products such as medicinal plants. Nonetheless, the inhibition mechanisms of many antibacterial phytochemicals remain elusive. Frequently, it is unclear which bacterial pathways or enzymes are being targeted.
In the efforts to discover potential therapeutic targets, as well as seeking for better understanding of their inhibition mechanisms, studies have been conducted to investigate the effects of antibacterial agents on bacterial gene expressions [1, 2] . For instance, using proteomic analysis methods, differentially expressed proteins have been identified in Gram-positive Staphylococcus aureus following exposure to silver (Ag), an active antibacterial agent incorporated in many healthcare products [3] . A similar approach has also been applied using plumbagin, an antimicrobial compound found in many medicinal plants [4] . Upon exposure to plumbagin, differentially expressed proteins from Gram-negative Escherichia coli have also been pinpointed.
Melastoma candidum (Melastomataceae family)
is a medicinal plant distributed in the tropical and subtropical areas, including Southeast Asia. Traditionally, this plant has been used to eliminate stasis, toxin cleansing and traumatic injury treatment [5] . Studies have indicated the presence of bioactivities, such as antihypertension [6] , free radical scavenging activities and monoamine oxidase inhibition activities in this plant extract [7] . Recent research works have also revealed M. candidum's broadspectrum antibacterial activities [5, 8] ; however, its inhibition mechanism remains unclear.
In this paper, we fractionated M. candidum extracts into different organic solvents and determined their corresponding minimum inhibition concentrations [9] . In our proteomic work, we identified and reported five differentially expressed bacterial proteins (four from E. coli and one from S. aureus), following exposure to M. candidum extracts. To the best of our knowledge, this represents the first time such bacterial protein targets are being reported in literature, in conjunction with M. candidum treatment. Additionally, we performed GC-MS analysis to study phytochemicals present in the active fraction. Through our works, we hope to shed light on some of the possible antibacterial therapeutic targets. Further works in this direction could potentially lead to the discovery and optimization of target-specific antibacterial agents.
EXPERIMENTAL Preparation of plant extracts
M. candidum were collected from April to June of 2012. The plant species was authenticated by Professor Dr. Hean-Chooi Ong at the Institute of Biological Sciences, University of Malaya, Malaysia. Voucher specimen (voucher no: MHR-2012-003) was deposited at Faculty of Science, Universiti Tunku Abdul Rahman. The plant materials (flowers) were dried in an oven at 40 ºC for 48 h or until constant weight was observed. Dried plant sample was then pulverized, followed by sequential extractions using hexane, ethyl acetate, acetone, methanol and distilled water. Supernatants were then filtered, concentrated and stored in -20 ºC until testing. 
Bacteria strains and culture conditions

Minimum inhibitory concentration (MIC) assay
MIC assays were performed using the published protocol with modifications [10, 11] . Briefly, a final bacterial inoculum of 5 × 10 5 cfu/ml was prepared using Mueller-Hinton Broth (MHB) and aliquoted into a 96-well sterile microtitre plate. Plant extracts were added into the first row of wells, and serial dilutions were performed to achieve final concentrations of 50, 25, 12.5, 6.3, 3.1, 1.6, 0.8 and 0.4 mg/ml. The sealed plate was then incubated at 37 ºC. After 18 -24 h, 20 µl of 0.4 mg/ml of p-iodonitrotetrazolium chloride (Fisher Scientific) was added to each well, followed by 30 min of incubation at 37 ºC. Color changes to pink were observed. The lowest sample concentration whereby no color change was observed and recorded as the MIC value. The reported MIC values represented average values of three identical replicate trials. Commercial ampicillin and kanamycin (SigmaAldrich) were used as positive controls. Sterility control and solvent control were also included in the MIC assays.
Isolation of bacterial protein for SDS-PAGE analysis
Bacterial cultures were treated with 2 -6 mg/ml of filtered plant extracts, and equivalence of solvents alone were used in negative controls. Bacterial cultures were then allowed to grow at 37 o C with constant shaking (200 rpm). At the intended time intervals (5, 30, 60 and 90 min), 20 ml of cultures were collected, and bacterial cells were harvested by refrigerated centrifugation at 9000 rpm for 10 min. Bacterial proteins were then extracted from the cell pellets and culture supernatants, using bacterial protein extraction reagent (Thermo Scientific) and ammonium sulfate precipitation.
SDS-PAGE gel electrophoresis and protein sequence analysis
SDS-PAGE gel electrophoresis was performed using 12 % resolving gel [1.5 M Tris-HCl, pH 8.8 (Bio Basic Canada, Inc), 10 % SDS (Fisher Scientific), 40 % bis-acrylamide] and 4 % stacking gel [0.5 M Tris-HCl (pH 6.9), 10 % SDS, 40 % bis-acrylamide]. Before being loaded into the wells, bacterial proteins were treated with dithiothreitol (DTT) and boiled. For ease of molecular weight estimation and comparison, protein ladder (Spectra Multicolor Broad-Range Protein Ladder, Thermo Scientific) was loaded onto each gel. The SDS-PAGE gels were run using constant electric current (135 mV) until the bromophenol blue dye front reached the bottom of the gel plate. Protein gels were then stained with Coomassie Brilliant Blue R-250 (Fisher Scientific) staining solution for an hour, followed by overnight destaining in distilled water. Differentially expressed protein bands were then excised using sterile razor blades and subjected to analysis by MALDI TOF-TOF mass spectrometry (4800 Proteomics Analyzer, AB Sciex) (Proteomics International, Perth, Australia). Spectra were analyzed using Mascot sequence matching software (Matrix Science) with Ludwig NR Database to identify the proteins of interest.
Thin layer chromatography (TLC) bioautobiography
TLC bioautobiography was performed as previously described [12] , with modification. Briefly, 0.2 mg of the plant extract (methanol fraction) was spotted at 1.5 cm from the base of a TLC plate (Silica Gel 60 F254, Merck) and developed using a 9:1 methanol:chloroform mobile phase. Two duplicate TLC plates were run concurrently: Plate A was used for bioautography, while Plate B was used to extract the spots containing antibacterial compounds. Plate A was developed as described above and then placed in a sterile petri dish. Next, 0.1 ml of bacteria culture (1 × 10 6 cfu/ml) was mixed into 10 ml of nutrient agar, and the agar was distributed over Plate A. Once the agar solidified, Plate A was incubated at 37 o C. After 24 h of incubation, 0.2 mg/ml of p-iodonitrotetrazolium violet solution was sprayed onto the agar. Clear zone on the agar indicated phytochemical fraction with bacterial inhibitory activity. Corresponding spot was determined on Plate B, and the silica gel was extracted with a spatula. Bioactive compounds were eluted from the silica gel using methanol. After centrifugation and subsequent filtration, the supernatant was then subjected to GC-MS analysis.
Gas chromatography-mass spectrometry (GC-MS) analysis of TLC spots
TLC spots were analyzed by gas chromatography equipped with mass spectrometry (GCMS-QP2010 Plus, Shidmadzu). The flow rate of the carrier gas (helium) was set to 1 ml/min, and the ion source was set to 280 o C. The total running time of the gas chromatography was 36 min. The mass spectra were obtained from the range of m/e 40 to 700. The identities of the samples were determined by comparing the mass spectra with NIST Gas Chromatography Library database.
Statistical analysis
Data were reported as mean ± standard errors, obtained from three replicate trials. Statistical analysis was performed using SAS (Version 9.2). Data were analyzed using ANOVA test, and significant differences between means were separated using Fisher's Least Significant Difference test at p < 0.05.
RESULTS
In our work, the M. candidum was fractionated into organic solvents with different polarities and tested for their inhibition activities against a total of seven bacterial strains (Table 1) . Bacterial inhibition activities were observed with M. candidum extracts fractionated into water, methanol and acetone. No inhibition was observed with the hexane extract, whereas ethyl acetate extract was found to inhibit only one strain of bacteria tested. The strongest bacterial inhibition activity was observed with methanol extract, followed by water and acetone extracts. The strong inhibition activities of methanol extract were indicated by its low MIC values (0.31 -5 mg/ml). Next, by using proteomic approach, we aimed to identify differentially expressed bacterial proteins. In this effort, we focused on using two bacterial strains as the models, with representatives from Gram-negative (E. coli 35218) and Gram-positive (S. aureus 6538) bacteria. Following treatment with the M. candidum extract, bacterial cellular proteins were extracted and prepared using Bacterial Protein Extraction Reagents (Thermo Scientific) and ammonium sulfate precipitation. In the negative control, M. candidum extract was substituted with solvent alone as treatment. Purified bacterial proteins were then separated on denaturing polyacrylamide electrophoresis gels. Figure 1a showed the protein expression profile of E. coli at different time intervals, following exposure to M. candidum extract. Here, a total of four differentially expressed bacterial proteins (as indicated by letters a to d) were identified, excised and subjected to analysis by MALDI TOF-TOF mass spectrometer. The identities and characteristics of these proteins were summarized and reported in Table 2 .
Additionally, in order to determine the effects of M. candidum extract on the bacterial secretomics profiles, we resolved to use ammonium sulfate precipitation to isolate bacterial proteins secreted into the culture mediums, upon exposure to M. (Figure 1b) . The protein was excised and subjected to sequence determination by MS. Based on protein sequencing result, the identity of this protein was determined to be α-hemolysin (a bacterial exotoxin protein)( Table 2) . We also attempted, without success, to identify differentially expressed exoprotein from other bacterial strains, following exposure to M. candidum extract (data not shown). Lastly, we used GC-MS analysis to determine the phytochemicals present in the M. candidum extract. From the GC spectrum, seven major peaks were identified (Figure 2) . Peaks 1 to 7 were selected and subjected to MS analysis. The identities and characteristics of these peaks were determined and summarized in Table 3 .
DISCUSSION
Since the medieval age, medicinal plants have been utilized by different ethnic groups for assorted medicinal purposes, including but not limited to antibacterial applications. Recent advances in analytical science have enabled the identification of an ever expanding library of plant-derived bioactive compounds, noticeably those with antibacterial activities. These plantderived secondary metabolites are of a diverse chemical nature, including different derivatives of phenolic acids, flavonoids, alkaloids and terpenoids compounds. Yet, relatively few studies have focused on illustrating and explaining how these medicinal plants exert their bacterial inhibitory activities. In most cases, it remains elusive which bacterial enzymes or pathways are actually affected by these antibacterial medicinal plants.
It is hoped that with more knowledge gained regarding the antibacterial mechanisms of these medicinal plants, potential therapeutic targets in bacteria could be revealed. The revelation of these novel targets could facilitate the design and enhancement of powerful antibacterial agents. This sure will be welcoming news in a world faced with increasing cases of multi-drug resistant bacteria.
In our study, we chose to focus on M. candidum, a medicinal plant with broad-spectrum antibacterial activities. In general, it is more challenging to inhibit Gram-negative bacteria, as they are protected by the presence of outer membranes [13] and efflux pumps [14] . Interestingly, the M. candidum was found to inhibit both Gram-negative and Gram-positive bacteria, including E. coli, P. aeruginosa and MRSA. Our fractionation and MIC results suggested that the antibacterial compounds in M. candidum extract may most likely be those of the polar family, as the strongest activities were observed with aqueous and methanol fractions.
In our GC-MS analysis of the methanol fraction, a total of seven compounds were identified. Literature search revealed that Compound 3 (phenol, dimethyl) [15] and Compound 6 (hexadecanoic acid, methyl ester) [15] [16] [17] have previously been reported with antibacterial activities. Meanwhile, a closely related derivative (hexadecanoic acid, ethyl ester), fractionated using ethanol from Brazilian M. subsericea, was reported with antibacterial activities in a separate study [18] . The bromo derivative of Compound 1 (butanoic acid, butyl ester) has also been tested with antibacterial activities [19] . In addition, the presence of Compound 5 (phthalate) has previously been reported in the aerial parts of B. retusa, [20] and C. serrata [21] . Both of these plant species demonstrated inhibitory activities against E. coli, S. aureus and P. aeruginosa. Interestingly, synthetic derivatives of Compound 4 (1-propanone) has previously been reported with inhibitory activities against E. coli and S. aureus [22, 23] .
In our proteomic analysis, a total of five differentially expressed bacterial proteins were identified. To the best of our knowledge, this represents the first time such bacterial protein targets are being reported in literature, upon exposure to M. candidum extract. Formate cacetyltransferase is an enzyme involved in bacterial glucose and pyruvate metabolism [24] , while glutamic acid decarboxylase (GAD) is utilized by bacteria to counteract the influx of protons from acidic environment, [25] . This feature of GAD enables the enteric bacteria such as E. coli to survive in the acidic environment of animal stomach. Interestingly, the expression level of elongation factor Tu (EF-Tu) was also affected by M. candidum. As EF-Tu interacts specifically with tRNAs during the protein elongation process, it is tempting to speculate that M. candidum extract may exert its inhibitory action via the bacterial protein translation pathway. This discovery is especially exciting considering that the protein translation process is critically essential to the bacteria survival, and it is highly conserved across different species of bacteria. [26] . It remains to be determined whether M. candidum extract affected EF-Tu in a similar mechanism as kirromycin, a commercial antibiotic targeting the bacterial EF-Tu [27, 28] . Lastly, we also detected reduced α-hemolysin expression in the growth medium of S. aureus. α-Hemolysin is reported as a pore-forming exotoxin secreted by many pathogens, and it targets the host immune cells [29] . Multiple studies have also indicated the roles of this exotoxin in tissue barrier disruption and the subsequent lethal infection [30] .
CONCLUSION
Our study has identified five bacterial proteins with reduced expression levels, upon treatment with M. candidum extract. Three of these bacterial proteins are especially noteworthy as potential therapeutic targets, namely GAD, EFTu and α-hemolysin. Inhibition of these bacterial targets may likely prove fatal to the invading bacterial strains, by rendering the bacteria vulnerable in acidic environment (human stomach), unable to replicate (by blocking the translation pathway) and reduced virulence (by repressing the expression of membranedamaging exotoxin), respectively. Currently, it remains unclear how the bioactive compounds from M. candidum influenced these bacterial proteins. To complicate matters further, the question of whether one compound inhibited the bacteria single-handedly or a group of these compounds worked synergistically needs to be addressed too. It is hoped that further works in this direction could potentially lead to the discovery of effective therapeutic agents similar to that or better than kirromycin. 
